1-4 of 4
Daniel J. Crusan
Close
Sort by
Journal Articles

Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US

Clinical Trials & Observations
John A. Heit, Daniel J. Crusan, Aneel A. Ashrani, Tanya M. Petterson, Kent R. Bailey
Journal: Blood
Blood (2017) 130 (2): 109–114.
https://doi.org/10.1182/blood-2016-12-758995
Published: 2017
Includes: Supplemental data
Journal Articles

Trends in the Incidence of Venous Thromboembolism Adjusted for Body Mass Index (BMI).

Cohoon P. Kevin, D.O., Aneel A. Ashrani, MBBS, MSc, Tanya M. Petterson, M.S., Daniel J. Crusan, Kent R Bailey, John A Heit
Journal: Blood
Blood (2012) 120 (21): 2256.
https://doi.org/10.1182/blood.V120.21.2256.2256
Published: 2012
Journal Articles

Are Beta-Receptor and Angiotensin-Blocking Drugs Protective Against Venous Thromboembolism (VTE)? A Population Based Case-Control Study

Aneel A. Ashrani, MBBS, MSc, Wencheng Geng, Daniel J. Crusan, Tanya M. Petterson, Kent R. Bailey, PhD, Cynthia L. Leibson, PhD, John A. Heit, MD
Journal: Blood
Blood (2010) 116 (21): 5118.
https://doi.org/10.1182/blood.V116.21.5118.5118
Published: 2010
Journal Articles

Incidence of Cancer-Associated Venous Thromboembolism (VTE): A Population-Based Cohort Study

Aneel A. Ashrani, M.B., B.S., M.Sc., John A. Heit, M.D., Daniel J. Crusan, B.S., Tanya M. Petterson, M.S., Kent R. Bailey, Ph.D., L. Joseph Melton, III, M.D.
Journal: Blood
Blood (2008) 112 (11): 3822.
https://doi.org/10.1182/blood.V112.11.3822.3822
Published: 2008